Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Dermatology · JAMA Dermatol · 2026-10-01
RCTn = 1,399
Mostaghimi et al. Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical TrialsDermatology · Acta Derm Venereol · 2026-08-04
Meta-analysisn = 9,103
Sanz-Cabanillas et al. Systemic Comorbidities in Central Centrifugal Cicatricial Alopecia: A Systematic Review and Meta-analysisDermatology · Clin Exp Dermatol · 2026-07-24
RCTn = 204 women
Jha et al. Spironolactone vs. bicalutamide in female pattern hair loss: a randomized clinical trialDermatology · Br J Dermatol · 2026-07-17
RCTn = 94
King et al. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trialDermatology · J Eur Acad Dermatol Venereol · 2026-05-26
Meta-analysisn = 29,000
Krebs et al. Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patientsDermatology · J Am Acad Dermatol · 2026-05-14
RCTn = 46
Tang et al. Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trialDermatology · J Eur Acad Dermatol Venereol · 2026-03-18
Guideline
Seyed Jafari et al. Management of classic lichen planopilaris: The EADV task force on hair diseases position statementDermatology · J Am Acad Dermatol · 2025-11-27
RCTn = 517
Tsianakas et al. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trialDermatology · J Am Acad Dermatol · 2025-11-26
Secondary analysisn = 196
Senna et al. Maintenance of long-term efficacy with continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2